CAS 2641646-59-3

Paridiprubart

CAS: 2641646-59-3

Purity: 95%

Molecular weight: G/Mol

Ref: IN-DA02AICN

Paridiprubart

CAS: 2641646-59-3

Paridiprubart (NI-0101) is a humanised monoclonal antibody targeting TLR4, ameliorative effects in COVID-19 patients with ARDS and rheumatoid arthritis.

Purity: 96.9% (SDS-PAGE); 98.5% (SEC-HPLC) - 96.9% (SDS-PAGE); 98.5% (SEC-HPLC)

Color and Shape: Transparent Liquid

Molecular weight: 145.16 kDa (Predicted)

Ref: TM-T74427